🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
78.47
+1.90 (2.47%)
Nov 18, 2026, 12:51 PM EST - Market open

Disc Medicine Statistics

Total Valuation

Disc Medicine has a market cap or net worth of $3.57 billion. The enterprise value is $2.95 billion.

Market Cap3.57B
Enterprise Value 2.95B

Important Dates

The last earnings date was Thursday, November 5, 2026, before market open.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

Disc Medicine has 45.54 million shares outstanding. The number of shares has increased by 15.11% in one year.

Current Share Class 45.54M
Shares Outstanding 45.54M
Shares Change (YoY) +15.11%
Shares Change (QoQ) +0.57%
Owned by Insiders (%) 0.44%
Owned by Institutions (%) 92.62%
Float 40.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 539.58
PB Ratio 4.89
P/TBV Ratio 5.77
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 20.30, with a Debt / Equity ratio of 0.10.

Current Ratio 20.30
Quick Ratio 19.87
Debt / Equity 0.10
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -60.91

Financial Efficiency

Return on equity (ROE) is -41.29% and return on invested capital (ROIC) is -26.08%.

Return on Equity (ROE) -41.29%
Return on Assets (ROA) -24.90%
Return on Invested Capital (ROIC) -26.08%
Return on Capital Employed (ROCE) -39.82%
Weighted Average Cost of Capital (WACC) 15.11%
Revenue Per Employee n/a
Profits Per Employee -$1.41M
Employee Count173
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Disc Medicine has paid $317,000 in taxes.

Income Tax 317,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.53% in the last 52 weeks. The beta is 2.00, so Disc Medicine's price volatility has been higher than the market average.

Beta (5Y) 2.00
52-Week Price Change -13.53%
50-Day Moving Average 71.56
200-Day Moving Average 70.91
Relative Strength Index (RSI) 50.58
Average Volume (20 Days) 1,017,666

Short Selling Information

The latest short interest is 6.86 million, so 15.07% of the outstanding shares have been sold short.

Short Interest 6.86M
Short Previous Month 7.46M
Short % of Shares Out 15.07%
Short % of Float 17.09%
Short Ratio (days to cover) 4.77

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -264.88M
Pretax Income -242.79M
Net Income -243.10M
EBITDA -264.52M
EBIT -264.88M
Earnings Per Share (EPS) -$6.33
Full Income Statement

Balance Sheet

The company has $682.82 million in cash and $61.09 million in debt, with a net cash position of $621.73 million or $13.65 per share.

Cash & Cash Equivalents 682.82M
Total Debt 61.09M
Net Cash 621.73M
Net Cash Per Share $13.65
Equity (Book Value) 604.25M
Book Value Per Share 15.65
Working Capital 663.05M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$189.94 million and capital expenditures -$20,000, giving a free cash flow of -$189.96 million.

Operating Cash Flow -189.94M
Capital Expenditures -20,000
Depreciation & Amortization 358,000
Net Borrowing 29.98M
Free Cash Flow -189.96M
FCF Per Share -$4.17
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Disc Medicine does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -15.11%
Shareholder Yield -15.11%
Earnings Yield -8.06%
FCF Yield -5.45%

Analyst Forecast

The average price target for Disc Medicine is $127.69, which is 62.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target $127.69
Price Target Difference 62.74%
Analyst Consensus Strong Buy
Analyst Count 13
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1